Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6716 |
Valsartan
Diovan,缬沙坦,Tareg,CGP 48933 |
RAAS | Endocrinology/Hormones |
Valsartan (CGP 48933) 是一种血管紧张素 II 受体拮抗剂,有用于高血压和心力衰竭的研究潜力。 | |||
T2318 |
Sacubitril/Valsartan
Sacubitril mixture with Valsartan,沙库必曲/缬沙坦,Valsartan,Sacubitril,LCZ696 |
Apoptosis; RAAS; Neprilysin | Apoptosis; Endocrinology/Hormones; Metabolism |
Sacubitril/Valsartan (LCZ696),以1:1摩尔比由Valsartan(一种ARB)和Sacubitril(AHU377)组成,为创新口服血管紧张素受体-脑啡肽酶(ARN)双重抑制剂,旨在治疗高血压与心力衰竭。其作用机制包括抑制炎症、氧化应激及细胞凋亡,有助于改善糖尿病心肌病。 | |||
T67848 |
Valsartan Methyl Ester
|
RAAS | Endocrinology/Hormones |
Valsartan Methyl Ester 是一种强效血管紧张素II 受体拮抗剂,IC50=0.06uM。 | |||
T13282 |
Valsartan-d9
CGP-48933 D9,缬沙坦 D9 |
Others | Others |
Valsartan D9 is a deuterium-labeled valsartan. Valsartan is an antagonist of the angiotensin II receptor and for the treatment of high blood pressure and heart failure. | |||
T19112 |
2R,4S-Sacubitril
LCZ 696杂质A,Sacubitril Enantiomer,ahu377 isomer 2 |
Others | Others |
2R,4S-Sacubitril (Sacubitril Enantiomer) 是 Sacubitri 杂质。其中 Sacubitril 与缬沙坦联合使用,表现出抗心力衰竭的活性。 |